Logo image
In situ depot comprising phase-change materials that can sustainably release a gasotransmitter H2S to treat diabetic wounds
期刊文章   同儕審查

In situ depot comprising phase-change materials that can sustainably release a gasotransmitter H2S to treat diabetic wounds

Wei-Chih Lin, Chieh-Cheng Huang, Shu-Jyuan Lin, Meng-Ju Li, Yen Chang, Yu-Jung Lin, Wei-Lin Wan, Po-Chien ShihHsing-Wen Sung
Biomaterials, 卷.145, 頁碼.1-8
11/2017

摘要

Angiogenesis Drug delivery Gasotransmitter Hydrogen sulfide Refractory wound Bioengineering Ceramics and Composites Biophysics Biomaterials Mechanics of Materials
Patients with diabetes mellitus are prone to develop refractory wounds. They exhibit reduced synthesis and levels of circulating hydrogen sulfide (H 2 S), which is an ephemeral gaseous molecule. Physiologically, H 2 S is an endogenous gasotransmitter with multiple biological functions. An emulsion method is utilized to prepare a microparticle system that comprises phase-change materials with a nearly constant temperature of phase transitions to encapsulate sodium hydrosulfide (NaHS), a highly water-labile H 2 S donor. An emulsion technique that can minimize the loss of water-labile active compounds during emulsification must be developed. The as-prepared microparticles (NaHS@MPs) provide an in situ depot for the sustained release of exogenous H 2 S under physiological conditions. The sustained release of H 2 S promotes several cell behaviors, including epidermal/endothelial cell proliferation and migration, as well as angiogenesis, by extending the activation of cellular ERK1/2 and p38, accelerating the healing of full-thickness wounds in diabetic mice. These experimental results reveal the strong potential of NaHS@MPs for the sustained release of H 2 S for the treatment of diabetic wounds.

相關連結

指標

1 檢視次數

詳細資料

Logo image